Although the healthcare industry relies on the patient to take medications responsibly; in 2017, close to 18 million individuals were reported to have misused prescription drugs, in the US. In fact, data from a National Survey on Drug Use and Health conducted in the same year, showed that an estimated 2 million Americans misused prescription pain relievers for the first time in the previous year. Moreover, the same study reported 1.5 million people abusing tranquilizers, over 1 million abusing prescription stimulants and more than 270,000 abusing sedatives, for the first time, in the same time period.
I have highlighted below some of the most interesting insights from our study. You can also access additional details here.
Prescription drugs have the ability to sabotage the lives of individuals as much as illicit narcotic substances, such as cocaine and heroin. In fact, many people start using such medications legitimately; over time, they get addicted and are unable to quit, adding to the growing healthcare burden
A number of technologies currently claim to enable the development of drug formulations that are difficult to misuse, deterring addicts and illicit drug users from manipulating prescription medications
Altering drug release features is one of the most commonly used approaches to prevent misuse, and the primary focus is on opioid drugs; the market features the presence of both new entrants and established players
Although there are several types of technology platforms that are designed to develop difficult-to-abuse formulations of prescription pharmaceuticals, they differ in terms of efficacy and applicability
Over the years, more than 8,000 patents have been granted / filed related to abuse deterrent technologies, across the globe, indicating the growing research interest in this field
Increasing partnership activity within this domain is indicative of the growing interest of stakeholders in developing innovative abuse deterrent drug formulations
The upcoming opportunity in the market is likely to be driven by licensing activity and will depend on the capability of novel technologies to meet unmet drug delivery needs
The market share is likely to be distributed across different approaches and types of end products; developed regions are anticipated to continue to dominate, in terms of revenue generation potential, in the coming years
To learn more, please click here. For any queries / suggestions, please do not hesitate to contact us at firstname.lastname@example.org. Alternatively, you can place an Order by filling this Order Form.